Traynor Capital Management’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-7,360
| Closed | -$139K | – | 215 |
|
|
2022
Q1 | $139K | Hold |
7,360
| – | – | 0.02% | 180 |
|
|
2021
Q4 | $130K | Hold |
7,360
| – | – | 0.02% | 200 |
|
|
2021
Q3 | $272K | Hold |
7,360
| – | – | 0.04% | 148 |
|
|
2021
Q2 | $412K | Hold |
7,360
| – | – | 0.06% | 126 |
|
|
2021
Q1 | $493K | Buy |
7,360
+5,530
| +302% | +$370K | 0.08% | 108 |
|
|
2020
Q4 | $110K | Buy |
1,830
+1,630
| +815% | +$98K | 0.02% | 151 |
|
|
2020
Q3 | $14K | Buy |
+200
| New | +$14K | ﹤0.01% | 153 |
|
|
2018
Q1 | – | Sell |
-490
| Closed | -$147K | – | 191 |
|
|
2017
Q4 | $147K | Sell |
490
-36
| -7% | -$10.8K | 0.06% | 164 |
|
|
2017
Q3 | $134K | Buy |
526
+70
| +15% | +$17.8K | 0.06% | 157 |
|
|
2017
Q2 | $123K | Buy |
456
+56
| +14% | +$15.1K | 0.06% | 152 |
|
|
2017
Q1 | $96K | Sell |
400
-150
| -27% | -$36K | 0.05% | 148 |
|
|
2016
Q4 | $155K | Buy |
550
+150
| +38% | +$42.3K | 0.1% | 119 |
|
|
2016
Q3 | $119K | Buy |
400
+70
| +21% | +$20.8K | 0.08% | 119 |
|
|
2016
Q2 | $142K | Hold |
330
| – | – | 0.11% | 120 |
|
|
2016
Q1 | $105K | Buy |
330
+8
| +2% | +$2.55K | 0.08% | 109 |
|
|
2015
Q4 | $166K | Hold |
322
| – | – | 0.12% | 124 |
|
|
2015
Q3 | $94K | Sell |
322
-204
| -39% | -$59.6K | 0.08% | 118 |
|
|
2015
Q2 | $206K | Sell |
526
-50
| -9% | -$19.6K | 0.17% | 121 |
|
|
2015
Q1 | $174K | Buy |
576
+316
| +122% | +$95.5K | 0.17% | 111 |
|
|
2014
Q4 | $57K | Buy |
+260
| New | +$57K | 0.07% | 109 |
|